Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Nasopharyngeal Carcinoma
100%
Non-endemic
100%
Distant Metastasis
66%
Local Control
58%
Radiotherapy
50%
Single-center Retrospective Study
50%
Quality of Life
50%
Label-free Mass Spectrometry
50%
Intensity-modulated Radiotherapy
50%
Brain Metastases
50%
Formalin-fixed Paraffin-embedded Tissue
50%
European Cohort
50%
Local Recurrence
33%
Adjuvant Chemotherapy
25%
Common Terminology Criteria for Adverse Events (CTCAE)
25%
Proteomic Analysis
25%
Overall Survival Rate
16%
Hypothyroidism
16%
Biopsy-proven
16%
Cause of Death
16%
Risk of Death
16%
Platinum-based Chemotherapy
16%
Consecutive Patients
16%
Unknown Cause
16%
Xerostomia
16%
Local Survival
16%
Distant Metastasis-free Survival
16%
Regional Control
16%
WHO Grade III
16%
Local Progression
16%
Late Toxicity
16%
Non-cancer Death
16%
Multivariable
16%
Cognitive Function
14%
Quality of Life Assessment
14%
Global Quality of Life
14%
Biomarker Research
8%
Herpes Simplex
8%
HSV Virus
8%
Primary Nasopharyngeal Carcinoma
8%
Concurrent Chemoradiation
8%
Rare Cancer
8%
Biomarker Discovery
8%
Kaplan-Meier
8%
Median Survival
8%
Tumor
8%
Western Countries
8%
Metastatic Disease
8%
Mass Spectrometry Analysis
8%
Disease Biomarker
8%
Medicine and Dentistry
Nasopharynx Carcinoma
100%
Intensity Modulated Radiation Therapy
57%
Distant Metastasis
51%
Radiation Therapy
50%
Quality of Life
50%
Brain Metastasis
50%
Retrospective Study
50%
Mass Spectrum
50%
Proteomics
28%
Biological Marker
28%
Recurrent Disease
25%
Deterioration
21%
Adjuvant Chemotherapy
19%
Overall Survival
19%
Epstein Barr Virus
14%
Neoplasm
14%
Hypothyroidism
12%
Cancer Mortality
12%
Biopsy Technique
12%
Survival Rate
12%
Xerostomia
12%
Distant Metastasis Free Survival
12%
Quality of Life Assessment
7%
Weakness
7%
Herpes Simplex
7%
Prospective Study
7%
Whole Brain Radiotherapy
7%
Health Status
7%
Rank Sum Test
7%
Loss of Appetite
7%
Median Survival Time
7%
Diseases
7%
Metastatic Carcinoma
7%
Malignant Neoplasm
7%
Virus
7%
Chemoradiotherapy
7%
Metastasis Potential
7%
Pharmacology, Toxicology and Pharmaceutical Science
Distant Metastasis
50%
Retrospective Study
50%
Brain Metastasis
50%
Nasopharynx Carcinoma
50%
Chemotherapy
33%
Recurrent Disease
33%
Deterioration
21%
Xerostomia
16%
Overall Survival
16%
Cancer Mortality
16%
Survival Rate
16%
Distant Metastasis Free Survival
16%
Hypothyroidism
16%
Hair Loss
7%
Loss of Appetite
7%
Health Status
7%
Weakness
7%
Prospective Study
7%
Median Survival Time
7%